Cite
MLA Citation
Sheila Farrell et al.. “Regulatory news: Nulibry (fosdenopterin) approved to reduce the risk of mortality in patients with molybdenum cofactor deficiency type A: FDA approval summary.” Journal of inherited metabolic disease, vol. 44, no. 5, 2021, pp. 1085–1087. http://access.bl.uk/ark:/81055/vdc_100142195068.0x00004f